Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Mar 13, 2015 · 10-K · 72 days after period end · 0001193125-15-091072
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Net Income | -$20.62M | -$14.04M | -$7.74M | -$4.26M |
| EPS Diluted | -$0.71 | -$0.75 | -$0.51 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 13, 2015 · 72 d after period end
